UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056128
Receipt number R000064034
Scientific Title Evaluation of cutaneous sensory block area of the external oblique intercostal block: a prospective observational study
Date of disclosure of the study information 2024/11/12
Last modified on 2024/11/12 13:06:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of cutaneous sensory block area of the external oblique intercostal block: a prospective observational study

Acronym

Evaluation of cutaneous sensory block area of the external oblique intercostal block: a prospective observational study

Scientific Title

Evaluation of cutaneous sensory block area of the external oblique intercostal block: a prospective observational study

Scientific Title:Acronym

Evaluation of cutaneous sensory block area of the external oblique intercostal block: a prospective observational study

Region

Japan


Condition

Condition

Laparoscopic upper abdominal surgery

Classification by specialty

Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the distribution of cutaneous sensory block area after the external oblique intercostal block using a pinprick test.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cutaneous Sensory Block Area (CSBA) after external oblique intercostal block

Key secondary outcomes

1. Distribution of CSBA in the thoracoabdominal wall
2. The extent of dermatomal spread following the EOI block
3. Potential applicability of the block for major upper abdominal surgery incisions
4. The relationship between CSBA and body landmarks
5. Duration of sensory blockade
6. The quality of sonographic imaging during EOI block
7. Pain-related outcomes


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients aged 20 to 80 years
2. Patients scheduled for laparoscopic upper abdominal surgery
3. Patients with American Society of Anesthesiologist (ASA) physical status I-III

Key exclusion criteria

1. Allergy to the study drug
2. Body weight below 45 kg
3. Body mass index exceeding 40 kg/m2
4. History of thoracotomy or laparotomy
5. Neuropathy of the thoracoabdominal wall
6. Patients with poor capacity for consent
7. Severe hepatic or renal failure
8. Operation time exceeding 4 hours

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Fujino

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

+81-3-3813-3111

Email

t-fujino@juntendo.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Fujino

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

+81-3-3813-3111

Homepage URL


Email

t-fujino@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Juntendo University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee Faculty Of Medicine, Juntendo University

Address

3-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

+81-3-5802-1584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 09 Month 27 Day

Date of IRB

2024 Year 10 Month 10 Day

Anticipated trial start date

2024 Year 11 Month 14 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Thirty subjects meeting the inclusion criteria and consenting to participate, scheduled to undergo laparoscopic upper abdominal surgery at our institution between the start of the study and December 2025.


Management information

Registered date

2024 Year 11 Month 12 Day

Last modified on

2024 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064034